ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 91 filers reported holding ADICET BIO INC in Q1 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $144,668 | -39.2% | 59,534 | +44.2% | 0.01% | -50.0% |
| Q1 2023 | $237,888 | +39.1% | 41,300 | +253.3% | 0.01% | +42.9% |
| Q2 2022 | $171,000 | -63.4% | 11,690 | -50.0% | 0.01% | -65.0% |
| Q1 2022 | $467,000 | -25.2% | 23,400 | -34.5% | 0.02% | -48.7% |
| Q4 2021 | $624,000 | +355.5% | 35,700 | +168.4% | 0.04% | +200.0% |
| Q2 2021 | $137,000 | – | 13,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |